Trial Outcomes & Findings for Pain Management for Pectus Excavatum Repair (NCT NCT00413582)
NCT ID: NCT00413582
Last Updated: 2012-01-16
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
110 participants
Primary outcome timeframe
1 week
Results posted on
2012-01-16
Participant Flow
Patients were recruited from patients undergoing pectus excavatum repair.
All patients who consented were enrolled
Participant milestones
| Measure |
Epidural Group
Epidural analgesia arm of study
|
PCA Group
IV narcotic analgesia arm of study
|
|---|---|---|
|
Overall Study
STARTED
|
55
|
55
|
|
Overall Study
Completion of Study
|
55
|
55
|
|
Overall Study
COMPLETED
|
55
|
55
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Pain Management for Pectus Excavatum Repair
Baseline characteristics by cohort
| Measure |
Epidural Group
n=55 Participants
Epidural analgesia arm of study
|
PCA Group
n=55 Participants
IV narcotic analgesia arm of study
|
Total
n=110 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
49 Participants
n=99 Participants
|
53 Participants
n=107 Participants
|
102 Participants
n=206 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
6 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
8 Participants
n=206 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Age Continuous
|
15.3 years
STANDARD_DEVIATION 2.84 • n=99 Participants
|
13.55 years
STANDARD_DEVIATION 2.91 • n=107 Participants
|
14.43 years
STANDARD_DEVIATION 2.99 • n=206 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=99 Participants
|
18 Participants
n=107 Participants
|
28 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
45 Participants
n=99 Participants
|
37 Participants
n=107 Participants
|
82 Participants
n=206 Participants
|
|
Region of Enrollment
United States
|
55 participants
n=99 Participants
|
55 participants
n=107 Participants
|
110 participants
n=206 Participants
|
PRIMARY outcome
Timeframe: 1 weekOutcome measures
| Measure |
Epidural Group
n=55 Participants
Epidural analgesia arm of study
|
PCA Group
n=55 Participants
IV narcotic analgesia arm of study
|
|---|---|---|
|
Length of Hospitalization
|
4.54 days
Standard Deviation 1.01
|
4.25 days
Standard Deviation 1.00
|
SECONDARY outcome
Timeframe: 1 weekOutcome measures
| Measure |
Epidural Group
n=55 Participants
Epidural analgesia arm of study
|
PCA Group
n=55 Participants
IV narcotic analgesia arm of study
|
|---|---|---|
|
Time in the Operating Room
|
1.97 hours
Standard Deviation .35
|
1.58 hours
Standard Deviation .33
|
Adverse Events
Epidural Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
PCA Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place